Statement of the half-yearly financial report (January 1 – June 30, 2024)
Engineering for a better world
Advancing continuous pharmaceutical manufacturing
GEA and partners innovate flexible continuous processing technologies, transforming pharmaceutical development and manufacturing for a modernized future.
GEA continues profitable growth in the first quarter of 2024 and confirms outlook for full year
GEA maintained its profitable growth trend in the first quarter of 2024. The company achieved organic revenue growth of 2.7 percent and a significant one-percentage-point increase in the EBITDA margin despite the persistently...
Shareholders approve GEA’s Climate Transition Plan 2040 by an overwhelming 98.4%
In a groundbreaking vote at today’s Annual General Meeting, GEA Group AG’s shareholders approved by an overwhelming majority the Climate Transition Plan 2040 presented to them.
GEA extends Chief Financial Officer Bernd Brinker’s contract until 2027
At its meeting today, GEA Group Aktiengesellschaft’s Supervisory Board extended the appointment of Bernd Brinker (59) as Chief Financial Officer (CFO) ahead of schedule until June 30, 2027. A member of the Executive Board since...
